New peroxisome proliferatoractivated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease

Amirhossein Sahebkar; Gerard Chew; Gerald Watts

New peroxisome proliferatoractivated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease

Amirhossein Sahebkar, Gerard Chew, Gerald Watts

Graduate Research School

Research output: Contribution to journal › Review article

Original language	English
Pages (from-to)	493-503
Journal	Expert Opinion on Pharmacotherapy
Volume	15
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{e0d0b5c248f94a8d95c9c5893fcd7c2b,

title = "New peroxisome proliferatoractivated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease",

author = "Amirhossein Sahebkar and Gerard Chew and Gerald Watts",

year = "2014",

language = "English",

volume = "15",

pages = "493--503",

journal = "Expert Opinion on Pharmacotherapy",

issn = "1465-6566",

publisher = "Informa Healthcare USA",

}

TY - JOUR

T1 - New peroxisome proliferatoractivated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease

AU - Sahebkar, Amirhossein

AU - Chew, Gerard

AU - Watts, Gerald

PY - 2014

Y1 - 2014

M3 - Review article

SN - 1465-6566

VL - 15

SP - 493

EP - 503

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

ER -